Keyphrases
Irinotecan
100%
Metastatic Colorectal Cancer (mCRC)
100%
Cetuximab
100%
Tumor-free
100%
Standardized Uptake Value
100%
Third-line Treatment
100%
Nontumor
100%
Fluorodeoxyglucose
50%
Positron Emission Tomography-computed Tomography (PET-CT)
50%
Fluoride
50%
Free Region
50%
Free Tissue
50%
Volume-of-interest
25%
Liver
25%
Metabolic Response
25%
Correlation Coefficient
25%
Aortic Arch
25%
In Cancer
25%
Cancer Cells
25%
Spleen
25%
Single Administration
25%
Total Body Mass
25%
Medicine and Dentistry
Neoplasm
100%
Standardized Uptake Value
100%
Irinotecan
100%
Cetuximab
100%
Metastatic Colorectal Cancer
100%
Positron Emission Tomography-Computed Tomography
40%
Fluorine-18
40%
Computer Assisted Tomography
20%
Aortic Arch
20%
Cancer Cell
20%
Single Drug Dose
20%
Metabolism
20%
Nursing and Health Professions
Neoplasm
100%
Irinotecan
100%
Cetuximab
100%
Standardized Uptake Value
100%
Metastatic Colorectal Cancer
100%
Positron Emission Tomography-Computed Tomography
40%
Fluorine 18
40%
Malignant Neoplasm
20%
Body Mass
20%
Computer Assisted Tomography
20%
Correlation Coefficient
20%
Single Drug Dose
20%
Biochemistry, Genetics and Molecular Biology
Positron Emission Tomography-Computed Tomography
100%
Cetuximab
100%
2-Deoxy-D-Glucose
100%
Body Mass
50%
Metabolic Pathway
50%
Single Drug Dose
50%
Cancer Cell
50%
Computer Assisted Tomography
50%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Irinotecan
100%
Metastatic Colorectal Cancer
100%
Cetuximab
100%
Fluorine 18
40%
Malignant Neoplasm
20%